Alemtuzumab Biosimilar - Research Grade

In stock
Only %1 left
SKU
ICH4002
Add to Compare
Rating:
100 % of 100
$306.00

Bulk Alemtuzumab Biosimilar - Research Grade

Product Specific Citations:

Gravina et al. Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression. Nature Biotechnology (2023). 

Gravina et al. Synthetic immune checkpoint engagers protect HLA-deficient iPSCs and derivatives from innate immune cell cytotoxicity. Cell Stem Cell 30, 1538–1548

Iadonato et al. A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumors. Front Immunol. 2023; 14: 1311658.

 

Product Benefits:

ichorbio's Alemtuzumab Biosimilar - Research Grade is manufactured in a cGMP compliant facility. Our alemtuzumab biosimilar is for research use only (RUO).

Size:

ichorbio's research grade alemtuzumab biosimilar is available in the following sizes: 5mg, 10mg, 20mg, 50mg, 100mg ichorbio regularly manufactures bulk multi-gram amounts of our alemtuzumab biosimilar - please contact us for pricing.

Target:

CD52

Clone:

n/a

Isotype:

IgG1 kappa

Other Names:

Campath-1 antigen, Cambridge pathology 1 antigen, HE5

Host:

Humanized

Species Reactivity:

Human

Specificity:

Detects human CD52.

Purification Method:

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Background:

Alemtuzumab biosimilar is a recombinant DNA-derived humanized monoclonal antibody (Campath-1H) directed against the 21-28 kD cell surface glycoprotein, CD52, is an IgG1 kappa antibody with human variable framework and constant regions, and complementarity-determining regions from a murine (rat) monoclonal antibody. The alemtuzumab biosimilar has an approximate molecular weight of 150 kD and is produced in mammalian cell (Chinese hamster ovary) suspension culture in a medium.

Concentration:

1.0 - 5.0 mg/ml

Formulation:

Sterile, clear, colorless, preservative-free solution with a pH value of 6.8-7.4 and contains sodium chloride, disodium hydrogen phosphate, potassium chloride, potassium dihydrogen phosphate, polysorbate 80 and EDTA two sodium. BSA and Azide free.

Purity:

>95% by SDS-PAGE and HPLC

Endotoxin:

≤ 0.75 EU/mg as determined by the LAL method

Storage:

Alemtuzumab Biosimilar - Research Grade is stable for at least four (4) weeks when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.

Applications:

Functional Assays

Application Notes:

Each investigator should determine their own optimal working dilution for specific applications.

Use: ichorbio's alemtuzumab biosimilar is for research use only (RUO). Isotype Control:

Bulk Human IgG1 Isotype Control (IB1) [ICH2254]

Bulk Alemtuzumab Biosimilar - Research Grade

More Information
Product Specific Citations

Gravina, A., Tediashvili, G., Rajalingam, R. et al. Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression. Nat Biotechnol 41, 717–727 (2023).

Gravina et al. Synthetic immune checkpoint engagers protect HLA-deficient iPSCs and derivatives from innate immune cell cytotoxicity. Cell Stem Cell 30, 1538–1548

Iadonato et al. A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumors. Front Immunol. 2023; 14: 1311658.

Concentration 6.02mg/ml
Isotype IgG1 kappa
Host Humanized
Use Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Storage Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at ï؟½80°C. Avoid Repeated Freeze Thaw Cycles.
Endotoxin ≤ 1.0 EU/mg as determined by the LAL method
Purity >95% by SDS-PAGE and HPLC
Formulation Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.
Purification Method This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Specificity Detects human CD52. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Alemtuzumab.
Species Reactivity Human
Target CD52
Shipping Conditions Blue ice
background Alemtuzumab biosimilar is a recombinant DNA-derived humanized monoclonal antibody (Campath-1H) directed against the 21-28 kD cell surface glycoprotein, CD52, is an IgG1 kappa antibody with human variable framework and constant regions, and complementarity
Other names Campath-1 antigen, Cambridge pathology 1 antigen, HE5
UniProt P31358
Buffer ICH3001-100ml ICH3002-100ml ICH3003-100ml
Sequence https://www.imgt.org/mAb-DB/

Product Benefits:

ichorbio's Alemtuzumab Biosimilar - Research Grade is manufactured in a cGMP compliant facility. Our alemtuzumab biosimilar is for research use only (RUO).

Size:

ichorbio's research grade alemtuzumab biosimilar is available in the following sizes: 5mg, 10mg, 20mg, 50mg, 100mg ichorbio regularly manufactures bulk multi-gram amounts of our alemtuzumab biosimilar - please contact us for pricing.

Write Your Own Review
You're reviewing:Alemtuzumab Biosimilar - Research Grade
Your Rating
Back to Top